Effect of Carvedilol on Plasma Adiponectin Concentration in Patients With Chronic Heart Failure
Authors:
Open Access
- 1 January 2009
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 73 (6) , 1067-1073
Abstract
Background: Patients with a high plasma adiponectin have a poor prognosis in chronic heart failure (CHF). Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are reported to increase the plasma adiponectin concentration, but the effect of β-blockers on plasma adiponectin in patients with CHF remains unknown. Methods and Results: Blood samples were collected at before and 6 months after administration of carvedilol in 44 CHF patients. The hemodynamic parameters, echocardiography, plasma concentrations of brain natriuretic peptide (BNP), norepinephrine and adiponectin were measured. Six months after treatment, there were significantly decreased plasma concentrations of adiponectin (15.8 ±1.4 to 11.0 ±1.1 μg/ml, P<0.0001), BNP and norepinephrine and increased left ventricular ejection fraction (LVEF). On stepwise multivariable analyses, a higher plasma adiponectin concentration before treatment (rs=-0.561, P<0.0001) was a significant independent predictor of a greater decrease in adiponectin concentration and the decrease in plasma adiponectin concentration was significantly correlated with the improvement of LVEF (r=-0.561, P<0.0001). Conclusions: These findings indicate that carvedilol decreases plasma adiponectin concentration and that the decrease in plasma adiponectin is associated with the improvement of LVEF after treatment with carvedilol in CHF patients. (Circ J 2009; 73: 1067-1073)Keywords
This publication has 36 references indexed in Scilit:
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta, 2007
- Hypoadiponectinemia Is an Independent Risk Factor for HypertensionHypertension, 2004
- Plasma Adiponectin Levels and Risk of Myocardial Infarction in MenJAMA, 2004
- Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese PopulationDiabetes Care, 2003
- Decreased plasma adiponectin concentration in patients with essential hypertensionAmerican Journal of Hypertension, 2003
- Association of Hypoadiponectinemia With Coronary Artery Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation, 2002
- Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive SubstancesAnnals of the New York Academy of Sciences, 1999
- Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in ObesityBiochemical and Biophysical Research Communications, 1999